Timestamps: 0:00 Intro 00:51 Could you give us an update about what has been happening regarding convalescent plasma? 03:46 What are some take-home points from this new AABB guidelines that are out? 15:07 Were there challenges discussed or things that you see these guidelines either domestically or internationally? 18:20 Is there an aspect that you would like to see addressed with more robust data as we go forward? 20:12 Outro
